Gilead Sciences Canada, Inc.
Registration:
1
of
1
(2020-07-14
to
2020-07-14)
Details Regarding the Identified Subject Matter
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
Client has requested assistance to arrange meetings to advocate for the approval of a plan for the introduction and implementation of CAR-T cell replacement therapy in B.C.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|